CVRx (CVRX) Return on Capital Employed (2021 - 2026)
CVRx's (CVRX) quarterly Return on Capital Employed came in at 53.88% in Q1 2026, down 1266.0% year-on-year from 4.62% in Q1 2025, and little changed quarter-over-quarter from 54.11% in Q4 2025.
CVRx (CVRX) Return on Capital Employed (2021 - 2026) Analysis & Trends
CVRx's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 53.88% for Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 1266.0% year-over-year to 53.88% in Q1 2026; TTM through Mar 2026 was 53.88%, a 1266.0% decrease from a year earlier, with the FY2025 full-year figure at 48.46%, up 393.0% from the prior year.
- Return on Capital Employed was little changed at 53.88% in Q1 2026 per CVRX's latest filing, from 54.11% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 22.31% in Q1 2022 and bottomed at 60.24% in Q2 2024.
- The 5-year median for Return on Capital Employed is 43.49% (2023), against an average of 43.9%.
- Across the five-year window, Return on Capital Employed slumped 2003 bps in 2022 and soared 1577 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 36.14% in 2022, then retreated by 16 bps to 41.87% in 2023, then declined by 19 bps to 49.67% in 2024, then fell by 9 bps to 54.11% in 2025, then advanced by 0 bps to 53.88% in 2026.
- Per Business Quant, the three latest CVRX Return on Capital Employed figures stand at 53.88% (Q1 2026), 54.11% (Q4 2025), and 48.31% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | -53.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.88% |
| Dec 31, 2025 | -54.11% |
| Sep 30, 2025 | -48.31% |
| Jun 30, 2025 | -44.48% |
| Mar 31, 2025 | -41.22% |
| Dec 31, 2024 | -49.67% |
| Sep 30, 2024 | -58.36% |
| Jun 30, 2024 | -60.24% |
| Mar 31, 2024 | -51.98% |
| Dec 31, 2023 | -41.87% |
| Sep 30, 2023 | -43.49% |
| Jun 30, 2023 | -41.42% |
| Mar 31, 2023 | -38.65% |
| Dec 31, 2022 | -36.14% |
| Sep 30, 2022 | -32.41% |
| Jun 30, 2022 | -27.76% |
| Mar 31, 2022 | -22.31% |
| Dec 31, 2021 | -16.11% |
| Sep 30, 2021 | -17.63% |